← FDA DRUG APPROVALS

FDA ANDA · ANDA072410

INDOMETHACIN

Sponsor: INWOOD LABS

APPLICATION
ANDA072410
TYPE
ANDA
ORIGINAL APPROVAL
1989-03-15
LATEST ACTION
1998-04-15
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

INDOMETHACINDiscontinued
INDOMETHACIN 75MG · CAPSULE, EXTENDED RELEASE · ORAL

Approval history

1998-04-15Manufacturing (CMC) · Supplement 12AP
1995-11-28Manufacturing (CMC) · Supplement 11AP
1995-07-28Manufacturing (CMC) · Supplement 2AP
1993-08-05Labeling · Supplement 8AP
1993-04-02Labeling · Supplement 7AP
1992-12-09Labeling · Supplement 6AP
1992-11-09Manufacturing (CMC) · Supplement 5AP
1992-04-17Labeling · Supplement 4AP
1991-04-15Manufacturing (CMC) · Supplement 1AP
1989-03-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →